Literature DB >> 421556

Reexpansion pulmonary edema.

V K Mahajan, M Simon, G L Huber.   

Abstract

A case of pulmonary edema following reexpansion of a collapsed lung due to pneumothorax is described and illustrated. The importance of recognizing this relatively uncommon phenomenon is stressed. The development of such edema can be prevented by avoiding application of sudden and excessive negative pleural pressures during the evacuation of a pneumothorax or a pleural effusion. The edema generally occurs in a lung that has been collapsed for more than three days. The importance of the duration of pulmonary collapse in the causation of edema is demonstrated in this patient.

Entities:  

Mesh:

Year:  1979        PMID: 421556     DOI: 10.1378/chest.75.2.192

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Reexpansion pulmonary edema following reconstruction of a traumatic hernia of the diaphragm.

Authors:  M Okuda; H Amano; T Kurata; Y Ogura; A Yoshimura; Y Ikeda; M Muneyuki
Journal:  J Anesth       Date:  1995-03       Impact factor: 2.078

2.  Use of a protease inhibitor, ulinastatin, for reexpansion pulmonary edema following evacuation of bilateral pleural effusion.

Authors:  S Yamada; Y Nishida; K Yamazaki; H Kato
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

3.  Changes in pulmonary microvascular permeability accompanying re-expansion oedema: evidence from dual isotope scintigraphy.

Authors:  P D Wilkinson; J Keegan; S W Davies; J Bailey; R M Rudd
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

4.  Bilateral reexpansion pulmonary edema associated with pleural empyema: a case report.

Authors:  Muhammet Sukru Paksu; Sule Paksu; Muhammet Akgün; Ayhan Gazi Kalaycı; Kemal Baysal
Journal:  Eur J Pediatr       Date:  2011-03-11       Impact factor: 3.183

5.  Hydrostatic mechanisms may contribute to the pathogenesis of human re-expansion pulmonary edema.

Authors:  Richard D Sue; Michael A Matthay; Lorraine B Ware
Journal:  Intensive Care Med       Date:  2004-07-17       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.